维康药业
(300878)
| 流通市值：43.27亿 | | | 总市值：43.47亿 |
| 流通股本：1.44亿 | | | 总股本：1.45亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 181,618,377.67 | 137,417,137.22 | 263,080,649.55 | 272,998,138.15 |
| 交易性金融资产 | 10,284,780.82 | 10,021,208.77 | 10,000,000 | 10,000,000 |
| 应收票据及应收账款 | 144,724,881.98 | 124,879,325.95 | 108,606,185.82 | 113,962,905.85 |
| 其中：应收票据 | 6,095,141.83 | 15,521,832.58 | - | - |
| 应收账款 | 138,629,740.15 | 109,357,493.37 | 108,606,185.82 | 113,962,905.85 |
| 应收款项融资 | 3,575,489.51 | 13,837,085.6 | 23,814,789.36 | 21,111,712.28 |
| 预付款项 | 2,257,977.18 | 2,094,105.39 | 5,180,424.55 | 1,960,945.91 |
| 其他应收款合计 | 11,829,872.54 | 11,640,680.63 | 14,917,425.03 | 13,527,455.6 |
| 存货 | 54,819,625.15 | 60,871,199.14 | 83,555,057.67 | 108,072,791.68 |
| 其他流动资产 | 21,326,788.31 | 22,489,515.83 | 23,859,474 | 27,701,615.92 |
| 流动资产合计 | 430,437,793.16 | 383,250,258.53 | 533,014,005.98 | 569,335,565.39 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 12,500,000 | 12,500,000 | 25,000,000 | 25,000,000 |
| 投资性房地产 | 18,775,466.13 | 18,897,202.28 | 19,030,563.8 | 22,059,611.11 |
| 固定资产 | 708,188,742.14 | 714,498,537.32 | 756,857,717.25 | 770,263,047.08 |
| 在建工程 | 40,044,474.27 | 40,211,310 | 57,799,756.06 | 58,662,829.13 |
| 使用权资产 | 3,775,150.92 | 4,381,834.05 | 5,106,109.29 | 5,723,175.34 |
| 无形资产 | 29,967,635.65 | 30,086,098.27 | 32,257,131.15 | 32,701,640.23 |
| 商誉 | - | - | 10,894,160.95 | 10,917,833.64 |
| 长期待摊费用 | 11,272,839.86 | 12,005,924.54 | 3,489,217.48 | 2,484,315.62 |
| 递延所得税资产 | 32,505,427.36 | 35,230,040.84 | 43,564,630.45 | 47,838,743.2 |
| 其他非流动资产 | - | 167,468 | 990,000 | 990,000 |
| 非流动资产合计 | 857,029,736.33 | 867,978,415.3 | 954,989,286.43 | 976,641,195.35 |
| 资产总计 | 1,287,467,529.49 | 1,251,228,673.83 | 1,488,003,292.41 | 1,545,976,760.74 |
| 流动负债: | | | | |
| 短期借款 | 138,348,158.75 | 63,342,308.75 | - | - |
| 应付票据及应付账款 | 26,630,458.5 | 47,009,180.85 | 65,692,233.74 | 70,741,767.23 |
| 应付账款 | 26,630,458.5 | 47,009,180.85 | 65,692,233.74 | 70,741,767.23 |
| 预收款项 | 111,474.5 | 739,131.08 | 110,851.08 | 211,231.41 |
| 合同负债 | 5,556,259.58 | 8,767,003.56 | 20,782,616.87 | 14,012,336.56 |
| 应付职工薪酬 | 4,256,769.9 | 8,313,903.32 | 5,584,548.05 | 4,439,803.7 |
| 应交税费 | 17,360,743.91 | 21,170,556.76 | 17,512,714.26 | 15,720,400.37 |
| 其他应付款合计 | 17,915,583.39 | 19,415,062.63 | 24,847,248.57 | 25,307,694.45 |
| 一年内到期的非流动负债 | 9,930,329.17 | 9,930,329.17 | 90,775,071.12 | 90,250,071.12 |
| 其他流动负债 | 1,161,268.77 | 6,737,005.24 | 2,701,307.24 | 1,821,170.8 |
| 流动负债合计 | 221,271,046.47 | 185,424,481.36 | 228,006,590.93 | 222,504,475.64 |
| 非流动负债: | | | | |
| 长期借款 | 89,962,564.17 | 89,954,525 | 182,120,952.19 | 182,120,952.19 |
| 租赁负债 | 1,342,759.37 | 1,713,929.16 | 3,076,665.42 | 4,478,534.19 |
| 递延收益 | 40,968,824.2 | 42,030,396.81 | 37,841,969.67 | 40,377,542.53 |
| 递延所得税负债 | 8,371,831.16 | 8,379,150.48 | 7,324,645.44 | 7,348,318.13 |
| 非流动负债合计 | 140,645,978.9 | 142,078,001.45 | 230,364,232.72 | 234,325,347.04 |
| 负债合计 | 361,917,025.37 | 327,502,482.81 | 458,370,823.65 | 456,829,822.68 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 144,790,322 | 144,790,322 | 144,790,322 | 144,790,322 |
| 资本公积 | 680,767,826.97 | 680,767,826.97 | 680,767,826.97 | 680,767,826.97 |
| 减:库存股 | 49,998,351.8 | 49,998,351.8 | 49,998,351.8 | 49,998,351.8 |
| 盈余公积 | 65,194,788.4 | 65,194,788.4 | 65,194,788.4 | 65,194,788.4 |
| 未分配利润 | 71,423,663.24 | 69,683,238.88 | 173,170,380.83 | 232,805,291.59 |
| 归属于母公司股东权益合计 | 912,178,248.81 | 910,437,824.45 | 1,013,924,966.4 | 1,073,559,877.16 |
| 少数股东权益 | 13,372,255.31 | 13,288,366.57 | 15,707,502.36 | 15,587,060.9 |
| 股东权益合计 | 925,550,504.12 | 923,726,191.02 | 1,029,632,468.76 | 1,089,146,938.06 |
| 负债和股东权益合计 | 1,287,467,529.49 | 1,251,228,673.83 | 1,488,003,292.41 | 1,545,976,760.74 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |